---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-016524"
form_type: "8-K"
ticker: null
cik: "0001838821"
company_name: "ARYA Sciences Acquisition Corp IV"
filed_at: "2023-04-05T23:59:59+00:00"
generated_at: "2026-06-17T06:02:20.069477+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ARYA Sciences restates Q3 2022 financials; underwriter commission waiver misclassified as gain rather than equity credit

## Summary
- Restating Q3 2022 financials because extinguishment of deferred underwriter commissions was incorrectly recorded as a gain instead of a credit to shareholders' deficit.
- No impact on liquidity, cash flows, trust account or operating expenses — only a classification change.
- Identified a material weakness in internal control over financial reporting and ineffective disclosure controls for the affected period.
- Restatement will be included in the 2022 10-K; audit committee and independent auditor have been informed.
- One underwriter waived its 50% share of deferred underwriting commissions in August 2022.

## SEC filing metadata
- accession: 0001140361-23-016524
- form_type: 8-K
- cik: 0001838821
- company_name: ARYA Sciences Acquisition Corp IV
- filed_at: 2023-04-05T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 4.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1838821/000114036123016524/0001140361-23-016524-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1838821/000114036123016524/brhc10050928_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-016524
- JSON: https://secwatch.observer/filing/0001140361-23-016524.json
- Plain text: https://secwatch.observer/filing/0001140361-23-016524.txt

## Key facts
- Auditor Changes
  ARYA Sciences Acquisition Corp IV reported that prior financial statements should not be relied upon.
  - Action: non reliance
  - Auditor: WithumSmith+Brown, PC
  source text: the Company’s management and the Audit Committee of the Company’s Board of Directors (the “Audit Committee”) concluded on April 4, 2023 that the financial statements for the Affected Period (as defined below) included in the Quarterly Report should no longer be relied upon
  evidence_url: https://www.sec.gov/Archives/edgar/data/1838821/000114036123016524/0001140361-23-016524-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.